USD 0.16
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 31.18 Million GBP | -37.47% |
2022 | 49.86 Million GBP | 5.4% |
2021 | 47.31 Million GBP | 21.17% |
2020 | 39.04 Million GBP | 27.72% |
2019 | 30.57 Million GBP | 32.82% |
2018 | 23.02 Million GBP | 25.92% |
2017 | 18.28 Million GBP | 67.45% |
2016 | 10.91 Million GBP | 62.01% |
2015 | 6.73 Million GBP | -39.94% |
2014 | 11.22 Million GBP | 82.14% |
2013 | 6.16 Million GBP | -18.12% |
2012 | 7.52 Million GBP | 45.09% |
2011 | 5.18 Million GBP | -1.31% |
2010 | 5.25 Million GBP | -2.76% |
2009 | 5.4 Million GBP | -0.86% |
2008 | 5.45 Million GBP | -40.63% |
2007 | 9.18 Million GBP | 18.57% |
2006 | 7.74 Million GBP | -51.97% |
2005 | 16.12 Million GBP | 0.0% |
2004 | 16.12 Million GBP | 33.68% |
2003 | 12.05 Million GBP | 1049.57% |
2002 | 1.04 Million GBP | -18.56% |
2001 | 1.28 Million GBP | -22.32% |
2000 | 1.65 Million GBP | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 32.98 Million GBP | 0.0% |
2024 Q1 | 32.98 Million GBP | 5.77% |
2023 Q1 | 40.16 Million GBP | -19.46% |
2023 FY | 31.18 Million GBP | -37.47% |
2023 Q3 | 31.18 Million GBP | -22.36% |
2023 Q4 | 31.18 Million GBP | 0.0% |
2023 Q2 | 40.16 Million GBP | 0.0% |
2022 Q3 | 49.86 Million GBP | 19.3% |
2022 Q2 | 41.8 Million GBP | 0.0% |
2022 Q1 | 41.8 Million GBP | -11.65% |
2022 FY | 49.86 Million GBP | 5.4% |
2022 Q4 | 49.86 Million GBP | 0.0% |
2021 Q2 | 34.75 Million GBP | 0.0% |
2021 Q4 | 47.31 Million GBP | 0.0% |
2021 FY | 47.31 Million GBP | 21.17% |
2021 Q1 | 34.75 Million GBP | -11.0% |
2021 Q3 | 47.31 Million GBP | 36.15% |
2020 Q2 | 29.5 Million GBP | 0.0% |
2020 Q4 | 39.04 Million GBP | 0.0% |
2020 Q3 | 39.04 Million GBP | 32.34% |
2020 FY | 39.04 Million GBP | 27.72% |
2020 Q1 | 29.5 Million GBP | 0.0% |
2019 Q3 | 34.73 Million GBP | 35.99% |
2019 Q1 | 23.02 Million GBP | 0.0% |
2019 FY | 30.57 Million GBP | 32.82% |
2019 Q2 | 25.54 Million GBP | 10.97% |
2018 Q1 | 18.28 Million GBP | 0.0% |
2018 Q3 | 25.54 Million GBP | 0.0% |
2018 FY | 23.02 Million GBP | 25.92% |
2018 Q4 | 23.02 Million GBP | -9.88% |
2017 Q4 | 18.28 Million GBP | 65.27% |
2017 Q3 | 11.06 Million GBP | 0.0% |
2017 Q2 | 11.06 Million GBP | 1.32% |
2017 Q1 | 10.91 Million GBP | 0.0% |
2017 FY | 18.28 Million GBP | 67.45% |
2016 Q2 | 13.63 Million GBP | 102.27% |
2016 Q1 | 6.73 Million GBP | 0.0% |
2016 Q3 | 13.63 Million GBP | 0.0% |
2016 Q4 | 10.91 Million GBP | -19.9% |
2016 FY | 10.91 Million GBP | 62.01% |
2015 FY | 6.73 Million GBP | -39.94% |
2015 Q2 | 8.63 Million GBP | -23.06% |
2015 Q3 | 8.63 Million GBP | 0.0% |
2015 Q4 | 6.73 Million GBP | -21.94% |
2015 Q1 | 11.22 Million GBP | 0.0% |
2014 Q3 | 4.82 Million GBP | 0.0% |
2014 Q4 | 11.22 Million GBP | 132.73% |
2014 FY | 11.22 Million GBP | 82.14% |
2014 Q2 | 4.82 Million GBP | -21.74% |
2014 Q1 | 6.16 Million GBP | 0.0% |
2013 FY | 6.16 Million GBP | -18.12% |
2013 Q2 | 7.03 Million GBP | -6.43% |
2013 Q3 | 7.03 Million GBP | 0.0% |
2013 Q4 | 6.16 Million GBP | -12.49% |
2013 Q1 | 7.52 Million GBP | -0.0% |
2012 FY | 7.52 Million GBP | 45.09% |
2012 Q4 | 7.52 Million GBP | 27.35% |
2012 Q3 | 5.9 Million GBP | 0.0% |
2012 Q2 | 5.9 Million GBP | 13.91% |
2012 Q1 | 5.18 Million GBP | 0.0% |
2011 FY | 5.18 Million GBP | -1.31% |
2011 Q3 | 4.45 Million GBP | 0.0% |
2011 Q1 | 5.25 Million GBP | 0.0% |
2010 Q3 | 6.15 Million GBP | 0.0% |
2010 FY | 5.25 Million GBP | -2.76% |
2010 Q1 | 5.4 Million GBP | 0.0% |
2009 Q3 | 5.72 Million GBP | 0.0% |
2009 Q1 | 5.45 Million GBP | 0.0% |
2009 FY | 5.4 Million GBP | -0.86% |
2008 FY | 5.45 Million GBP | -40.63% |
2008 Q3 | 7.74 Million GBP | 0.0% |
2008 Q1 | 9.18 Million GBP | 0.0% |
2007 FY | 9.18 Million GBP | 18.57% |
2007 Q3 | 10.41 Million GBP | 0.0% |
2007 Q1 | 7.74 Million GBP | 0.0% |
2006 Q1 | 16.12 Million GBP | 0.0% |
2006 FY | 7.74 Million GBP | -51.97% |
2006 Q3 | 10.65 Million GBP | 0.0% |
2005 Q1 | 10.05 Million GBP | 0.0% |
2005 FY | 16.12 Million GBP | 0.0% |
2005 Q3 | 9.8 Million GBP | 0.0% |
2004 Q3 | 11.16 Million GBP | 0.0% |
2004 Q1 | 12.05 Million GBP | 0.0% |
2004 FY | 16.12 Million GBP | 33.68% |
2003 FY | 12.05 Million GBP | 1049.57% |
2003 Q3 | 1.17 Million GBP | 0.0% |
2002 FY | 1.04 Million GBP | -18.56% |
2001 FY | 1.28 Million GBP | -22.32% |
2000 FY | 1.65 Million GBP | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Bio Medica Corporation | 1.26 Million USD | -2357.289% |
Arrayit Corporation | 1 Million USD | -3017.087% |
Atlantic International Corp. | 4.43 Million USD | -602.896% |
Biocept, Inc. | 30.87 Million USD | -1.004% |
Bioqual, Inc. | 56.58 Million USD | 44.895% |
CardioGenics Holdings Inc | 231.93 Thousand USD | -13344.889% |
DermTech, Inc. | 121.93 Million USD | 74.425% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.255% |
HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -75.406% |
iMD Companies, Inc. | 190.13 Thousand USD | -16300.28% |
IDenta Corp. | 1.52 Million USD | -1939.071% |
Interpace Biosciences, Inc. | 13.02 Million USD | -139.482% |
Integrative Health Technologies, Inc. | 8.25 Million USD | -277.888% |
InVitro International | 1.53 Million USD | -1932.781% |
Lumos Diagnostics Holdings Limited | 26.83 Million USD | -16.19% |
Many Bright Ideas Technologies Inc. | 2312.00 USD | -1348645.675% |
Medical Imaging Corp. | 4.19 Million USD | -643.935% |
NovelStem International Corp. | 2.25 Million USD | -1283.117% |
Optigenex Inc. | 1.88 Million USD | -1551.388% |
PharmChem, Inc. | 2.76 Million USD | -1027.548% |
Proteome Sciences plc | 14.58 Million USD | -113.787% |
Response Genetics, Inc | 48.88 Million USD | 36.21% |
Rennova Health, Inc. | 20.57 Million USD | -51.574% |
RushNet, Inc. | 6.04 Million USD | -415.626% |
ScreenPro Security Inc. | 1.26 Million USD | -2372.175% |
Stella Diagnostics Inc. | 472.42 Thousand USD | -6500.652% |
StageZero Life Sciences Ltd. | 700.65 Thousand USD | -4350.569% |
Todos Medical Ltd. | 15.26 Million USD | -104.251% |